Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Deloitte
UBS
US Army
Covington
Boehringer Ingelheim
Teva
Federal Trade Commission
Merck
Argus Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Bisoprolol fumarate - Generic Drug Details

« Back to Dashboard

What are the generic sources for bisoprolol fumarate and what is the scope of bisoprolol fumarate patent protection?

Bisoprolol fumarate
is the generic ingredient in four branded drugs marketed by Anda Repository, Aurobindo Pharma, Mylan, Orit Labs Llc, Sandoz, Teva Pharms, Unichem Pharms (usa), Teva Womens, Actavis Elizabeth, Apothecon, Ivax Sub Teva Pharms, Teva, Unichem, Watson Labs Teva, and Teva Branded Pharm, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for bisoprolol fumarate. Twelve suppliers are listed for this compound.
Pharmacology for bisoprolol fumarate
Medical Subject Heading (MeSH) Categories for bisoprolol fumarate

US Patents and Regulatory Information for bisoprolol fumarate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075579-003 Sep 25, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075768-002 Sep 25, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Teva BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075469-003 Sep 25, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Branded Pharm ZIAC bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 020186-003 Mar 26, 1993 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Branded Pharm ZIAC bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 020186-002 Mar 26, 1993 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075632-002 Sep 27, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075632-003 Sep 27, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem Pharms (usa) BISOPROLOL FUMARATE bisoprolol fumarate TABLET;ORAL 078635-001 Aug 18, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075672-003 Sep 25, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem Pharms (usa) BISOPROLOL FUMARATE bisoprolol fumarate TABLET;ORAL 078635-002 Aug 18, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for bisoprolol fumarate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Womens ZEBETA bisoprolol fumarate TABLET;ORAL 019982-002 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Teva Womens ZEBETA bisoprolol fumarate TABLET;ORAL 019982-001 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
QuintilesIMS
Accenture
Queensland Health
UBS
Moodys
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot